Dual-Functional Nanoliposome with High BPA Loading for Targeted MRI-Guided BNCT of Glioblastoma
- 6 September 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (37) , 52474-52487
Abstract
Glioblastoma is a highly malignant brain tumor with few available therapeutic options, for which boron neutron capture therapy (BNCT) has emerged as a promising precision radiotherapy approach. However, its efficacy remains suboptimal due to inadequate tumor targeting of boron agents and lack of in vivo visualization. Herein, a gadolinium-boron integrated lipid nanocarrier (BPA-F&DOTA-Gd@LIPO-ANG) was developed for targeted boron delivery and MRI-guided BNCT. BPA-F and DOTA-Gd were coloaded into lipid nanocarriers using a microfluidic system, with Angiopep-2 modification to enhance blood-brain barrier penetration and glioma targeting. Following cellular uptake, BPA-F&DOTA-Gd@LIPO-ANG effectively increased boron accumulation in glioma cells, inducing significant apoptosis and DNA damage upon neutron irradiation. Intravenously injected into orthotopic glioma model mice, BPA-F&DOTA-Gd@LIPO-ANG selectively accumulated in the tumor site, increasing tumor-to-normal tissue (T/N) and tumor-to-blood (T/B) ratios. Enhanced boron accumulation facilitated greater cytotoxic effects mediated by high-energy rays from the boron capture reaction, leading to significantly prolonged mice survival. In addition, in vitro and in vivo MRI validations confirmed its MRI visualization capability, meeting the demand for boron drug imaging for BNCT diagnosis and treatment integration. Overall, these results suggest that BPA-F&DOTA-Gd@LIPO-ANG is a promising targeted boron delivery system for MRI-guided BNCT in glioblastoma treatment.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFE0107800, 2023YFA1008600)
- National Natural Science Foundation of China (82073332, 82373206)
- Natural Science Foundation of Zhejiang Province (LHDMZ24H300002)
This publication has 55 references indexed in Scilit:
- Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCTCancer Communications, 2024
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatmentCancer Communications, 2022
- Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical studyCancer Communications, 2021
- Biocompatible Iron–Boron Nanoparticles Designed for Neutron Capture Therapy Guided by Magnetic Resonance ImagingAdvanced Healthcare Materials, 2020
- Boron neutron capture therapy: Current status and future perspectivesCancer Communications, 2020
- Radiation Therapy of Glioblastoma2014
- Boron neutron capture therapy for glioblastoma multiforme: clinical studies in SwedenJournal of Neuro-Oncology, 2003
- The Harvard-MIT BNCT Program2001
- Boron-Neutron Capture Therapy for Tumors1991